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Highlights: 
• Trunk-derived multipotent neural crest stem cells can be cultured as crestospheres  
• Trunk-derived crestospheres require different conditions than cranial 
• Trunk crestospheres consist of neural crest stem and progenitor cells 
• Trunk crestospheres can be efficiently transduced using lentiviral vectors 
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Abstract 
Neural crest cells have broad migratory and differentiative ability that differs according to their 
axial level of origin.  However, their transient nature has limited understanding of their stem 
cell and self-renewal properties. While an in vitro culture method has made it possible to 
maintain cranial neural crest cells as self-renewing multipotent crestospheres (Kerosuo et al., 
2015), these same conditions failed to preserve trunk neural crest in a stem-like state. Here we 
optimize culture conditions for maintenance of trunk crestospheres, comprised of both neural 
crest stem and progenitor cells. Trunk crestospheres display elevated expression of neural crest 
cell markers as compared to those characteristic of neural tube or mesodermal fates. Moreover, 
trunk crestospheres have increased expression of trunk-related markers as compared to cranial 
genes. Finally, we use lentiviral transduction as a tool to manipulate gene expression in trunk 
crestospheres. Taken together, this method enables long-term in vitro maintenance and 
manipulation of trunk neural crest cells in a premigratory stem or early progenitor state to probe 
the mechanisms underlying their stemness and lineage decisions.   
 
Keywords: crestospheres; neural crest stem cells; trunk neural crest; cranial neural crest; chick 
embryo; Gallus gallus; cell cultures, stem cell maintenance 
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Introduction 
 
The neural crest is a multipotent stem cell population that forms essential structures of the 
vertebrate body. Arising within the neuroectoderm after gastrulation, premigratory neural crest 
cells within the dorsal neural tube express numerous transcription factors including FOXD3, 
TFAP2 and SOXE (Khudyakov and Bronner-Fraser, 2009). Around the time of neural tube 
closure, neural crest cells delaminate from the neural tube by undergoing an epithelial-to-
mesenchymal transition (EMT), a feature shared with metastatic cancer cells, and then migrate 
extensively to populate distant sites in the embryo. In their final sites, neural crest cells 
differentiate into more than thirty different cell types, the range of which varies according to 
their anterior to posterior axial level of origin.   
 
Elegant quail-chick grafting experiments (Ayer-Le Lievre and Le Douarin, 1982) have shown 
that different populations of neural crest cells arise at different levels of the body axis 
designated from anterior to posterior as cranial, vagal, trunk and sacral. These four subdivisions 
all share the ability to form cells of the peripheral nervous system and melanocytes, but also 
give rise to axial level-specific features.  For example, facial bone/cartilage arise from cranial 
neural crest (Ayer-Le Lievre and Le Douarin, 1982) whereas chromaffin cells of the adrenal 
medulla only arise from the trunk (Vega-Lopez et al., 2018). 
 
The stem cell properties of neural crest cells make them a cell type of interest in regenerative 
medicine as well as a possible cell of origin for neural crest-derived tumors and birth defects 
(Vega-Lopez et al., 2018), highlighting the importance of understanding the regulatory 
mechanisms underlying neural crest stemness. To address this, we recently reported 
establishment of crestospheres for cranial neural crest cells. These are self-renewing 
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multipotent primary neural crest cultures derived from either chick embryos or human 
embryonic stem cells (Kerosuo et al., 2015). Crestospheres maintain neural crest cells as 
premigratory neuroepithelial cells and differ from previous culture techniques which induce 
spontaneous differentiation (Baroffio et al., 1988; Curchoe et al., 2010; Lee et al., 2007; 
Stemple and Anderson, 1992; Trentin et al., 2004). Under crestosphere conditions, 
premigratory neural crest cells retain multipotency on a clonal level (Kerosuo et al., 2015). 
Given that there are known axial level differences between neural crest populations and 
different signaling cascades that determine the anterior to posterior patterning of the vertebrate 
body, it is not surprising that the established cranial crestosphere conditions do not support 
maintenance of trunk-derived neural crest cells. 
 
To circumvent this problem, here, we provide conditions that enable long term growth of trunk 
crestospheres as epithelial spheres under stem cell-promoting culture conditions. Trunk 
crestospheres express general markers of the premigratory neural crest as well as genes specific 
to the trunk level, as shown by quantitative PCR, in situ hybridization and 
immunohistochemistry. Importantly, trunk neural crest-derived crestospheres can be efficiently 
transduced with fluorescently labelled lentiviral vectors.  Thus, they hold great promise as an 
in vitro model for examining trunk neural crest-associated birth defects and malignancies such 
as the childhood tumor form neuroblastoma. 
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Methods 
 
Chick embryos 
Chick embryos were obtained from commercially purchased fertilized eggs and incubated at 
37.5°C/100°F until the desired developmental stages. For trunk cultures, we used stage 13-/14+ 
(17-21 somite stage) embryos. For the cranial cultures used as controls, stage 8-/9 (4-7 somite 
stage) embryos were used, staged according to the criteria of Hamburger Hamilton (HH) 
(Hamburger and Hamilton, 1951). In a few cases, we tested cranial cultures from later stages 
when most of the neural crest has already migrated from the neural tube (i.e. HH10+).  
 
Neural tube dissection 
Embryos at designated somite stages were collected from the eggs by using Whatman filter 
paper with hole-punches. Embryos are placed in the center and transferred to Ringer’s balanced 
salt solution (Solution-1: 144g NaCl, 4.5g CaCl•2H2O, 7.4g KCl, ddH2O to 500ml; Solution-
2: 4.35g Na2HPO4•7H2O, 0.4g KH2PO4, ddH2O to 500ml (adjust final pH to 7.4). Embryos 
were detached from the filter paper and placed ventral side up to cut out the endoderm by 
“cutting from the ventral midline”. Neural tubes from respective axial levels were carefully 
dissected out, and all neighboring mesoderm and notochord tissue was removed. Isolated neural 
tubes were transferred to a small volume (50 µl) of sterile PBS. For cranial-derived cultures 
used as controls, the very anterior tip was excluded, and the neural tube was dissected until the 
first somite level as previously described (Kerosuo et al., 2015). For trunk-derived cultures, the 
neural tube was dissected between somites 10-15, and pools of neural tubes from 4 - 6 embryos 
were used for each culture. 
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Cell culture 
Pooled neural tubes were mechanically dissociated (~ 30 times until clumps of ~ 50-100 cells 
were formed) and transferred to NC medium (DMEM with 4.5g/L glucose, 7.5% chick embryo 
extract, 1X B27, basic fibroblast growth factor (bFGF, 20 ng/ml), insulin growth factor -I (IGF-
I, 20 ng/ml), retinoic acid (RA, 60nM for cranial and 180nM for trunk, respectively), and with 
or without 25 ng/ml BMP-4 in low-adherence T25 tissue culture flasks (2 ml (cranial) or 1.5ml 
(trunk) per flask in upright position). See Table 1 for complete culture conditions. During the 
course of 7-14 days, the total volume of media was incrementally increased to a maximum of 
Vtot=10ml. Due to rapid degradation, retinoic acid and BMP-4 were re-added to the culture 
medium volume every 2-3 days, and the spheres were also gently dispersed by pipetting up and 
down ~10-20 times against the culture flask wall every 2-3 days. 
 
RNA extraction and quantitative real-time PCR 
Total RNA was extracted using the RNAqeuous Micro Kit (Ambion) and eluted in 20µl elution 
solution. cDNA synthesis using random primers and qRT-PCR was performed as previously 
described (Mohlin et al., 2015). Relative mRNA levels were normalized to expression of two 
reference genes (18S, 28S) using the comparative Ct method (Vandesompele et al., 2002). See 
Table 2 for primer sequences.  
 
Whole mount in situ hybridization of embryos and crestospheres 
For whole mount in situ hybridization, embryos were fixed overnight in 4% paraformaldehyde 
(PFA) at +4°C, washed in PBS containing 0.1% Tween 20 with 0.1% DEPC (DEPC-PBT), 
dehydrated in a methanol (MeOH)/PBT series at room temperature and kept in 100% MeOH at 
-20°C until use (days or even months). In situ hybridization was performed as previously 
described (Acloque et al., 2008); briefly, embryos were rehydrated back to 100% PBT and 
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prehybridized in hybridization buffer for 2 hours at 70°C. Embryos were then hybridized with 
Digoxigenin (DIG)-labeled probes overnight at 70°C. The next day, embryos were washed in 
prehybridization buffer multiple times before switching to Maleic Acid Buffer (MAB) with 
0.1% Tween 20 (MABT). Embryos were then blocked in MABT solution with 10% Boehringer 
Blocking Reagent and 10% Sheep Serum for 2 hours and incubated with an anti-DIG antibody 
(1:2000) (Roche) in blocking solution overnight at 4°C. On day 3, embryos were washed in 
MABT throughout the day and then switched into Alkaline phosphatase buffer (NTMT; 
100mM NaCl, 100mM Tris-Cl (pH 9.5), 50mM MgCl2, 1%Tween-20) before visualizing the 
signal using nitroblue tetrazolium (NBT) and 5-Bromo-4-chloro-3-indolyl phosphate (BCIP) 
solutions (Roche). Embryos were fixed in 4% PFA for 20 minutes when they reached the 
desired state and dehydrated in MeOH to be stored at -20°C. Images of whole mount embryos 
were taken using an Axioskop2 (Zeiss) microscope equipped with Axiovision software, and a 
region between somites 10-15 was dissected and embedded in blocks of gelatin for transverse 
sectioning at 20 µm using a cryostat. 
 
Similarly, crestospheres were fixed in 4% PFA for 30 minutes at RT or overnight at +4°C and 
washed in DEPC-PBT. Samples were then gradually dehydrated by bringing them to 100% 
MeOH and kept at -20°C for a minimum of 2 hours (or long-term for months). In situ 
hybridization was performed as described above (Acloque et al., 2008). Avian DIG-labelled 
hybridization probes for SOX10, FOXD3, PAX7, SNAI2, SOX2 and SOX9 were cloned by using 
chicken cDNA as previously described (Khudyakov and Bronner-Fraser, 2009).  
 
Whole mount immunohistochemistry 
Crestospheres were fixed in 4% paraformaldehyde for 15 minutes at RT, washed three times in 
TBS-T (TBS + Ca2+ supplemented with 0.1% Triton-X) and blocked in 10% goat serum in 
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TBS-T for 4 hours at RT. Crestospheres were incubated with primary antibody (PAX7, 
Hybridoma Bank, 1:10) diluted in block solution over night at +4°C. After two times washing 
for 30 minutes in TBS-T, crestospheres were incubated with secondary antibody (goat anti-
mouse Alexa Fluor-594 [A11032]; 1:1000) and DAPI (Dako [D3571], 1:3000 diluted in 
blocking solution) for 4 hours at RT. Crestospheres were washed twice in TBS-T for 30 minutes 
before imaged mounting the crestospheres in cavity slides using the Slowfade anti-fade Kit 
(Dako, S2828). 
 
Lentiviral transduction 
Crestospheres were dissociated into single cells / small clusters by using Accutase (Sigma 
Aldrich; incubation at 37°C for 30 minutes) and seeded at high density in 150 µL culture 
medium in 24-well plates.  Cells were directly transduced with increasing concentrations of 
pCIG3-GFP (pCMV-IRES-GFP version 3, kind gift from Felicia Goodrum (Addgene plasmid 
# 78264) (Caviness et al., 2014)). Medium was changed twice a day for four consecutive days. 
GFP positivity was analyzed 96 hours post-transduction using an Olympus inverted 
fluorescence microscope. Virus titers were optimized and calculated using sphere growing 
neuroblastoma patient-derived xenograft cells (Persson et al., 2017) due to the difficulty in 
obtaining pure single cell suspensions of trunk crestosphere cultures. Two titers were tested; 
2.1*10^8 TU/ml and 2.3*10^8 TU/ml; TU, transducing units. 
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Results & discussion 
 
Optimization of the correct trunk premigratory axial level 
Cranial crestospheres grow as three-dimensional spheres under conditions optimized for neural 
tubes from chick embryos as well as human embryonic stem (ES) cells; these spheres retain 
their self-renewal capacity and multipotency for up to seven weeks in culture (Kerosuo et al., 
2015). Here, we sought to devise modifications that would enable growth and maintenance of 
premigratory neural crest cells from more posterior axial levels to provide a tool for studies on 
trunk neural crest stemness as well as trunk-derived neurocristopathies.  
 
To ensure that the proper stage from which to derive crestosphere cultures was used, we 
performed in situ hybridization on whole mount embryos using neural crest markers SOX10, 
FOXD3, PAX7, SOX9, SNAI2 and the neural marker SOX2 (Figure 1A-F). As expected the 
endogenous expression patterns showed that the trunk neural crest was premigratory at the level 
adjacent to somites 10-16 in stage HH13-/14 embryos.  
 
We tested our cranial crestosphere protocol on dissociated cell clusters of trunk neural tubes 
derived from chick embryos at several stages (HH10+, HH12, HH13/14), and confirmed that 
17-21 somite stage (HH13/14) embryos was the optimal developmental stage for trunk 
crestosphere culture establishment (Figure 2A). With HH13/14 embryos, spheres formed 
rapidly after tissue dissociation and expanded accordingly during in vitro culture, whereas trunk 
crestospheres derived from HH10+ or HH12 embryos grew slower and expressed lower levels 
of neural crest markers (data not shown). 
  
 
copyright under 17 USC 105 and is also made available for use under a CC0 license. 
preprint (which was not peer-reviewed) is the author/funder. This article is a US Government work. It is not subject to 
The copyright holder for this. http://dx.doi.org/10.1101/391599doi: bioRxiv preprint first posted online Aug. 14, 2018; 
 10 
Trunk neural crest cells do not survive in conditions optimized for cranial crestospheres 
Although it was initially possible to establish trunk crestospheres under culture conditions 
optimized for cranial crestospheres (Kerosuo et al., 2015), trunk crestospheres failed to thrive 
and expand long term. All cultures resulted in less than 25 spheres each during the entire 3 
week culture period (n=4). In comparison, all three simultaneously established cranial cultures 
produced 100+ spheres (n=3).  
 
Given the known importance of retinoic acid (RA) in posteriorizing the body axis as well as in 
caudal neural crest development (Kudoh et al., 2002; Martinez-Morales et al., 2011; Retnoaji 
et al., 2014), we increased the amount of RA in the culture medium from 60nM (Kerosuo et al., 
2015) to 180 nM. Visual observation of sphere growth suggested that 180nM of RA was 
optimal for successful expansion of trunk-derived crestospheres.  All cultures resulted in more 
than 50 to 100 spheres (n=6). Despite the additional supply of RA, trunk-derived crestosphere 
cultures continued to grow more slowly than cranial-derived cultures. We therefore optimized 
the starting culture volume by further decreasing it from 2 ml used for cranial crestospheres 
(Kerosuo et al., 2015) to 1.5 ml NC medium. This decrease in starting culture volume had a 
positive impact on trunk crestosphere expansion, suggesting that the crestospheres condition 
their own medium by producing additional essential growth factors. The number of spheres in 
each culture reached ~50 in less than 48 hours (n=3), equivalent to that observed for cranial-
derived spheres under optimal cranial crestosphere conditions. In similarity to previously 
established cranial crestospheres (Kerosuo et al., 2015), trunk crestosphere cultures grew and 
expanded in vitro for 6-7 weeks, after which they were still viable but virtually stopped to 
proliferate. 
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Trunk crestospheres are enriched for neural crest cells 
Next, we performed in situ hybridization to test expression of neural crest markers in our 
established sphere cultures. Trunk crestospheres showed strong expression of the neural crest 
markers SOX10 and SOX9 (Figure 2B), and as expected, we also detected some weaker level 
expression of the neural stem cell marker SOX2 (Figure 2B). Trunk crestospheres also 
contained PAX7 immunopositive cells, further confirming the enrichment of neural crest cells 
(Figure 2C). 
 
Trunk crestospheres are not enriched for mesodermal fates 
To further characterize gene expression patterns of the trunk crestosphere cultures, and to 
ensure lack of contamination from neighboring mesodermal cells, we used quantitative PCR 
(qPCR) to address expression levels of neural crest markers relative to markers that reflect the 
presence of mesodermal or mesenchymal fates. Consistent with in situ hybridization results, 
trunk crestospheres display increased expression of neural crest markers SOX10 and FOXD3, 
as well as B3GAT1 (encoding the enzyme required for formation of the HNK1-epitope; 
expressed in chicken neural crest), as compared to expression levels in whole embryos. 
Meanwhile, the relative expression levels of mesodermal/mesenchymal genes MYOD1 and T 
(T brachyury transcription factor) were low (Figure 3A). These results confirm the primarily 
neural crest identity of trunk crestospheres and rule out contamination by mesoderm- and/or 
mesenchymal-derived cells. 
 
Addition of BMP-4 to the culture medium promotes neural crest maintenance and expansion 
During normal development BMP-4 is secreted by the dorsal neural tube at the premigratory 
stage to promote neural crest fate (Liem et al., 1995), and later by the dorsal aorta, providing 
cues for neural crest cell migration as well as sympathoadrenal and chromaffin cell fate 
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(Unsicker et al., 2013). We therefore compared expression of neural crest genes in trunk 
crestosphere cultures without (i.e. ‘normal’ NC medium) or with BMP-4 supplement, testing 
whether addition of BMP-4 could increase relative expression levels of neural crest genes. By 
visual inspection, the crestospheres grew similarly with or without BMP4 (Figure 2A). 
However, expression of the early neural crest marker genes TFAP2B and SNAI2 increased 
(Figure 3B), and we also detected increased expression of NGFR, a marker expressed later by 
migrating and maturing peripheral neurons (Heuer et al., 1990) (Figure 3B). We conclude that 
BMP-4 further enriched neural crest fate in the cultures and should be routinely added to the 
optimized trunk crestosphere culture medium (Table 1). Altogether, we show that increased 
concentrations of RA are crucial for trunk crestosphere culture expansion (Table 1), and that 
BMP-4 enhances expression of at least some neural crest marker genes (Figure 3B). 
 
Trunk-derived crestospheres consist of a combination of neural crest stem and progenitor cells 
Next, we tested whether the trunk crestospheres consisted of a pure stem cell population of 
premigratory neural crest cells, or as shown in many spheroid cultures of different stem cell 
types, a mixture of cells at multiple developmental stages (Jensen and Parmar, 2006; Piscitelli 
et al., 2015). To this end, we performed qPCR to determine relative expression of genes 
associated with more progenitor-like neural crest cells including markers of the migratory stage 
as well as genes reflecting the sympathoadrenal lineage. The results show that trunk 
crestospheres contain a mixture of neural crest stem-like cells as well as progenitor cells (Figure 
3C). In addition, we observed enriched expression levels of recently characterized genes 
reflecting trunk neural crest, like HES6 (Murko et al., unpublished), in trunk crestospheres as 
compared to cranial crestospheres, reflecting the posterior axial levels of the trunk crestospheres 
(Figure 3C).  
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Trunk crestospheres can be efficiently transduced using lentiviral vectors 
Genetic manipulation of crestospheres is one potential application for analysis on downstream 
effects of genes of interest (Dupin et al., 2018; Kerosuo and Bronner, 2016). However, our 
previous attempts using siRNAs have demonstrated low transfection efficiency (Kerosuo and 
Bronner, 2016). Therefore, we sought to determine whether the trunk-derived crestospheres 
could be efficiently transduced using viral vectors to create stable phenotypes. In a proof-of-
principle experiment, we used a GFP-tagged lentiviral vector (pCMV-IRES-GFP version 3; 
pCIG3) and transduced trunk crestospheres with increasing concentrations of the virus. Trunk 
crestospheres did not display toxic side effects after viral transduction and survived well at all 
concentrations investigated. By analyzing GFP expression in individual spheres using live 
fluorescent microscopy, we observed no major differences in GFP intensity between the 
different viral concentrations tested (Figure 3D). These results show that trunk crestospheres 
can be efficiently transduced to create stable genotypes, overcoming the transient and 
inefficient nature of siRNAs. 
 
Conclusions 
Crestospheres are an excellent tool to study different aspects of neural crest stemness and 
differentiation (Dupin et al., 2018; Kerosuo and Bronner, 2016; Kerosuo et al., 2015).  Given 
the known axial level differences in the ability of cranial and trunk neural crest cells to give rise 
to different cell types (Ayer-Le Lievre and Le Douarin, 1982; Simoes-Costa and Bronner, 
2016), here we optimized previous cranial crestosphere conditions (Kerosuo et al., 2015) for 
maintenance of trunk-derived neural crest cultures that arise from more posterior axial levels 
(Figure 4). Our protocol for trunk crestosphere cultures results in enrichment of neural crest 
specific genes as shown by in situ hybridization, immunostaining and qPCR, with little 
expression of mesodermal or mesenchymal markers.  
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Trunk crestospheres are not only a useful tool for studying normal neural crest development, 
but also promise to be useful for advancing research on neural crest-derived diseases and 
malignancies, including neuroblastoma and pheochromocytoma, as well as syndromes like 
Congenital Central Hypoventilation Syndrome (CCHS), Familial Dysautonomia (FD), or von 
Hippel-Lindau Syndrome ((Huber et al., 2018; Tsubota and Kadomatsu, 2018; Zhang et al., 
2010).  Given the ability to perform viral transduction, trunk crestospheres promise to provide 
insight into the molecular mechanisms that govern normal development as well as diseases 
derived from the more posterior parts of the embryo.  
 
Acknowledgements 
This work was supported by the Swedish Childhood Cancer Foundation (to SM), the Mary 
Bevé Foundation (to SM), Magnus Bergvall’s Foundation (to SM), the Thelma Zoéga 
Foundation (to SM), Hans von Kantzow Foundation (to SM), the Royal Physiographic 
Society of Lund (to SM),  NIH Ruth L. Kirschstein NRSA F32HD087026 (to EK),  NIH 
R01DE024157 (to MB), the Academy of Finland (to LK), Sigrid Juselius Foundation (to LK), 
and in part by the Division of Intramural Research of the National Institute of Dental and 
Craniofacial Research at the National Institutes of Health, Department of Health and Human 
Services. 
  
copyright under 17 USC 105 and is also made available for use under a CC0 license. 
preprint (which was not peer-reviewed) is the author/funder. This article is a US Government work. It is not subject to 
The copyright holder for this. http://dx.doi.org/10.1101/391599doi: bioRxiv preprint first posted online Aug. 14, 2018; 
 15 
References 
Acloque, H., Wilkinson, D.G., Nieto, M.A., 2008. In situ hybridization analysis of chick 
embryos in whole-mount and tissue sections. Methods Cell Biol 87, 169-185. 
Ayer-Le Lievre, C.S., Le Douarin, N.M., 1982. The early development of cranial sensory 
ganglia and the potentialities of their component cells studied in quail-chick chimeras. Dev Biol 
94, 291-310. 
Baroffio, A., Dupin, E., Le Douarin, N.M., 1988. Clone-forming ability and differentiation 
potential of migratory neural crest cells. Proc Natl Acad Sci U S A 85, 5325-5329. 
Caviness, K., Cicchini, L., Rak, M., Umashankar, M., Goodrum, F., 2014. Complex expression 
of the UL136 gene of human cytomegalovirus results in multiple protein isoforms with unique 
roles in replication. J Virol 88, 14412-14425. 
Curchoe, C.L., Maurer, J., McKeown, S.J., Cattarossi, G., Cimadamore, F., Nilbratt, M., 
Snyder, E.Y., Bronner-Fraser, M., Terskikh, A.V., 2010. Early acquisition of neural crest 
competence during hESCs neuralization. PLoS One 5, e13890. 
Dupin, E., Calloni, G.W., Coelho-Aguiar, J.M., Le Douarin, N.M., 2018. The issue of the 
multipotency of the neural crest cells. Dev Biol. 
Hamburger, V., Hamilton, H.L., 1951. A series of normal stages in the development of the 
chick embryo. J Morphol 88, 49-92. 
Heuer, J.G., Fatemie-Nainie, S., Wheeler, E.F., Bothwell, M., 1990. Structure and 
developmental expression of the chicken NGF receptor. Dev Biol 137, 287-304. 
Huber, K., Janoueix-Lerosey, I., Kummer, W., Rohrer, H., Tischler, A.S., 2018. The 
sympathetic nervous system: malignancy, disease, and novel functions. Cell Tissue Res 372, 
163-170. 
Jensen, J.B., Parmar, M., 2006. Strengths and limitations of the neurosphere culture system. 
Mol Neurobiol 34, 153-161. 
copyright under 17 USC 105 and is also made available for use under a CC0 license. 
preprint (which was not peer-reviewed) is the author/funder. This article is a US Government work. It is not subject to 
The copyright holder for this. http://dx.doi.org/10.1101/391599doi: bioRxiv preprint first posted online Aug. 14, 2018; 
 16 
Kerosuo, L., Bronner, M.E., 2016. cMyc Regulates the Size of the Premigratory Neural Crest 
Stem Cell Pool. Cell Rep 17, 2648-2659. 
Kerosuo, L., Nie, S., Bajpai, R., Bronner, M.E., 2015. Crestospheres: Long-Term Maintenance 
of Multipotent, Premigratory Neural Crest Stem Cells. Stem Cell Reports 5, 499-507. 
Khudyakov, J., Bronner-Fraser, M., 2009. Comprehensive spatiotemporal analysis of early 
chick neural crest network genes. Dev Dyn 238, 716-723. 
Kudoh, T., Wilson, S.W., Dawid, I.B., 2002. Distinct roles for Fgf, Wnt and retinoic acid in 
posteriorizing the neural ectoderm. Development 129, 4335-4346. 
Lee, G., Kim, H., Elkabetz, Y., Al Shamy, G., Panagiotakos, G., Barberi, T., Tabar, V., Studer, 
L., 2007. Isolation and directed differentiation of neural crest stem cells derived from human 
embryonic stem cells. Nat Biotechnol 25, 1468-1475. 
Liem, K.F., Jr., Tremml, G., Roelink, H., Jessell, T.M., 1995. Dorsal differentiation of neural 
plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 82, 969-979. 
Martinez-Morales, P.L., Diez del Corral, R., Olivera-Martinez, I., Quiroga, A.C., Das, R.M., 
Barbas, J.A., Storey, K.G., Morales, A.V., 2011. FGF and retinoic acid activity gradients 
control the timing of neural crest cell emigration in the trunk. J Cell Biol 194, 489-503. 
Mohlin, S., Hamidian, A., von Stedingk, K., Bridges, E., Wigerup, C., Bexell, D., Pahlman, S., 
2015. PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and 
vascularization in neuroblastoma. Cancer Res 75, 4617-4628. 
Persson, C.U., von Stedingk, K., Bexell, D., Merselius, M., Braekeveldt, N., Gisselsson, D., 
Arsenian-Henriksson, M., Pahlman, S., Wigerup, C., 2017. Neuroblastoma patient-derived 
xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic 
capacities but differentiate in serum. Sci Rep 7, 10274. 
copyright under 17 USC 105 and is also made available for use under a CC0 license. 
preprint (which was not peer-reviewed) is the author/funder. This article is a US Government work. It is not subject to 
The copyright holder for this. http://dx.doi.org/10.1101/391599doi: bioRxiv preprint first posted online Aug. 14, 2018; 
 17 
Piscitelli, E., Cocola, C., Thaden, F.R., Pelucchi, P., Gray, B., Bertalot, G., Albertini, A., 
Reinbold, R., Zucchi, I., 2015. Culture and characterization of mammary cancer stem cells in 
mammospheres. Methods Mol Biol 1235, 243-262. 
Retnoaji, B., Akiyama, R., Matta, T., Bessho, Y., Matsui, T., 2014. Retinoic acid controls 
proper head-to-trunk linkage in zebrafish by regulating an anteroposterior somitogenetic rate 
difference. Development 141, 158-165. 
Simoes-Costa, M., Bronner, M.E., 2016. Reprogramming of avian neural crest axial identity 
and cell fate. Science 352, 1570-1573. 
Stemple, D.L., Anderson, D.J., 1992. Isolation of a stem cell for neurons and glia from the 
mammalian neural crest. Cell 71, 973-985. 
Trentin, A., Glavieux-Pardanaud, C., Le Douarin, N.M., Dupin, E., 2004. Self-renewal capacity 
is a widespread property of various types of neural crest precursor cells. Proc Natl Acad Sci U 
S A 101, 4495-4500. 
Tsubota, S., Kadomatsu, K., 2018. Origin and initiation mechanisms of neuroblastoma. Cell 
Tissue Res 372, 211-221. 
Unsicker, K., Huber, K., Schober, A., Kalcheim, C., 2013. Resolved and open issues in 
chromaffin cell development. Mech Dev 130, 324-329. 
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., Speleman, 
F., 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric 
averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034. 
Vega-Lopez, G.A., Cerrizuela, S., Tribulo, C., Aybar, M.J., 2018. Neurocristopathies: New 
insights 150 years after the neural crest discovery. Dev Biol. 
Zhang, D., Brinas, I.M., Binder, B.J., Landman, K.A., Newgreen, D.F., 2010. Neural crest 
regionalisation for enteric nervous system formation: implications for Hirschsprung's disease 
and stem cell therapy. Dev Biol 339, 280-294. 
copyright under 17 USC 105 and is also made available for use under a CC0 license. 
preprint (which was not peer-reviewed) is the author/funder. This article is a US Government work. It is not subject to 
The copyright holder for this. http://dx.doi.org/10.1101/391599doi: bioRxiv preprint first posted online Aug. 14, 2018; 
 18 
Figure legends 
Figure 1. Endogenous expression of premigratory neural crest markers in the posterior axial 
levels. (A-F) Whole mount in situ hybridization of HH13-14 embryos. A’-F’ Inserts showing 
the neural tube at the respective somite level that was dissected for trunk crestosphere cultures. 
(A’’-F’’) Transverse sections of the neural tubes at the level that was used for trunk crestosphere 
cultures. 
 
Figure 2. Trunk crestospheres are enriched for neural crest marker expression. (A) Trunk 
crestospheres cultured without or with BMP-4 in vitro grow in similar fashion. (B) In situ 
hybridization for SOX10 and SOX9. Trunk crestospheres also show weak expression of the 
neural stem cell marker SOX2. (C) PAX7 immunopositive neural crest cells in a trunk 
crestosphere.  
 
Figure 3. Quantitative PCR shows enriched neural crest gene expression in trunk crestospheres. 
(A) Relative mRNA expression of neural crest- and mesodermal/mesenchymal-associated 
genes comparing trunk crestosphere cultures (n=3) to stage HH10 wild type embryo (n=1, pool 
of three embryos). (B) Relative mRNA expression of neural crest-associated genes comparing 
trunk crestospheres cultured with (n=3) or without (n=3) BMP-4. (C) Relative mRNA 
expression levels of sympathoadrenal genes comparing trunk crestospheres cultured with BMP-
4 (n=3) to HH10 wild type embryo (n=1, pool of three embryos) and cranial crestosphere 
cultures (n=4). (A-C) Data is presented as mean of n ± SD, and significance between trunk 
crestospheres cultured with or without BMP-4 (B) and trunk crestosphere and cranial 
crestosphere cultures (C) was calculated using two-sided student’s t-test; *p<0.05, **p<0.01, 
***p<0.001. (D) GFP expression in individual trunk crestosphere cells transduced with 
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different concentration of the virus shows similar transfection efficiency at all conditions. TU; 
Transducing Units. 
 
Figure 4. Schematic figure of respective axial levels dissected for cranial and trunk 
crestospheres, and the main differences in the culture medium composition. 
 
Table 1. Culture medium optimized for trunk crestospheres. 
 
Table 2. Primer sequences used for quantitative PCR. 
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Crestospheres - Trunk 
 
Medium (NC) CFinal 
DMEM (with P/S)   
Chicken embryo extract 7.5% 
B27 1X 
IGF-I 20 ng/ml   
FGF 20 ng/ml   
Retinoic Acid 180 nM 
BMP-4 25 ng/ml  
  
  
DMEM Corning #10-013-CVR, with 4.5g/L Glucose 
Chick Embryo Extract (CEE) MP Biomedicals #092850145 
B27 Life Technologies #12587-010 – 50X 
Human recombinant IGF-I  Sigma Aldrich #SRP3069 – in ddH2O+5% Trehalose in PBS (1:1) 
Human recombinant bFGF Peprotech – in Tris 5mM pH7.6 
Retinoic acid Sigma Aldrich #R2625 - 10 mM in DMSO 
BMP-4 Peprotech #120-05 – in citric acid (pH3.0):PBS with 2mg/ml BSA (1:1) 
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Target gene 5' - 3'
18S (Reference gene) Fwd CCATGATTAAGAGGGACGGC
Rev TGGCAAATGCTTTCGCTTT
28S (Reference gene) Fwd GGTATGGGCCCGACGCT
Rev CCGATGCCGACGCTCAT
SOX2 Fwd GGCACCAATACCATGACGA
Rev CATGTGCGCGTAACTGTCC
SOX10 Fwd AGCCAGCAATTGAGAAGAAGG 
Rev GAGGTGCGAAGAGTTGTCC 
FOXD3 Fwd TCTGCGAGTTCATCAGCAAC 
Rev TTCACGAAGCAGTCGTTGAG 
B3GAT1 Fwd TTGTGGAGGTGGTGAGGA 
Rev GGCTGTAGGTGGGTGTAATG 
MYOD1 Fwd GATTTCCACAGACAACTCCACA
Rev TCACTCAGGTTTCCTCCTTCC
BRACHYURY Fwd CCTCAGTCAAGCGGGATGT
Rev GATGTGGGAGAGCGGTGTAG
TFAP2B Fwd CCCTCCAAAATCCGTTACTT 
Rev GGGGACAGAGCAGAACACCT 
SNAI2 Fwd TCCCATTAGCGATGAAGAAGA
Rev CCAACCCAGAGAAAGTGGAA
NGFR Fwd AGCAGGAGGAGGTGGAGAA 
Rev CCCGTGTGAAGCAGTCTATG 
HES6 Fwd GCTGATGGCTGATTCCAAAG
Rev TCGCAGGTGAGGAGAAGGT
AGPAT4 Fwd TGCTGGGCGTTCTAAATGG
Rev ACACTCCTGCTCATCTTCTGG
MOXD1 Fwd CGACAACCCAACATACACTGA
Rev AAGAGGCTGACCCAAAGACC
RASL11B Fwd GCTGGGCTGTGCTTTCTATG 
Rev GGTGCTGGTGGTCTGTTGTT 
FMN2 Fwd CCATCAGCCAGTCAAGAGGA 
Rev TAAAGCATCGGGAGCCAAAC 
TAGLN3 Fwd AGGCAGCATTTCCAGACC 
Rev ATGGGTTCGTTTCCCTTTG 
NRCAM Fwd TCATTCCGTGTGATTGCTGT 
Rev AAGGATTTTCATCGGGGTTT 
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